Position history for BlackRock, Inc.'s holdings in AMYLYX PHARMACEUTICALS INC
BlackRock, Inc. holds 8.8M shares of AMLX (AMYLYX PHARMACEUTICALS INC), worth $122.7M as of 2026-Q1. The position was decreased (-2.5% shares). AMLX represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$122.7M
Current Shares
8.8M
Total Value Change
+$114.1M
Total Shares Change
+6.5M
Other major holders of AMLX: FMR LLC, VIKING GLOBAL INVESTORS LP
Decreased |
| 8.8M |
-2.5% |
| $122.7M |
| 0.0% |
| $14.11 |
0 |
| 2025-Q4 | Increased | 9.1M | +26.8% | $109.4M | 0.0% | $12.00 | 37 |
| 2025-Q3 | Increased | 7.1M | +29.6% | $97M | 0.0% | $14.90 | 38 |
| 2025-Q2 | Increased | 5.5M | +130.8% | $35.3M | 0.0% | $6.33 | 47 |
| 2025-Q1 | Increased | 2.4M | +4.8% | $8.5M | 0.0% | $3.66 | 29 |
| 2024-Q4 | New | 2.3M | - | $8.6M | 0.0% | $3.84 | 38 |